Program
Timetable
Brief Program (English sessions only)
Special LectureSaturday, March 1, 2025, 10:10～11:10
～The Cutting Edge of PTCy-based HCT in the World～
- Chair
- Hirohisa Nakamae
- （Department of Hematology, Osaka Metropolitan University Graduate School of Medicine）
The Cutting Edge of PTCy-Based Transplant in the World
- Presenters
- Christopher Kanakry
- （Center for Immuno-Oncology, National Institutes of Health, USA）
The Current Status and Future of Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
- Shannon R. McCurdy
- （University of Pennsylvania, Perelman School of Medicine, USA）
Symposium
Symposium 2Friday, February 28, 2025, 8:40～10:40
Treatment Practices of CAR-T and Bispecific Antibodies
- Chair
- Satoshi Yoshihara
- （Department of Respiratory Medicine and Hematology, Hyogo Medical University）
- Dai Maruyama
- （Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research）
Optimal use and Indications of CAR-T Therapy and the Role of Allogeneic HSCT in Multiple Myeloma
- Presenters
- Taku Kikuchi
- （Department of Hematology, Japanese Red Cross Medical Center）
CAR T-cell therapy for B-cell non-Hodgkin lymphoma: Eligibility and toxicity management
- Shinichi Makita
- （Department of Hematology, National Cancer Center Hospital）
Positioning of Allo-SCT and BsAbs in Relapse After CAR-T Therapy
- María-Victoria Mateos
- （University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Spain）
Evolving CAR T Therapy: Insights from Real-World Clinical Experience
- Yi Lin
- （Cancer Regenerative Biotherapeutics, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, USA）
JSTCT-KSBMT Joint SymposiumFriday, February 28, 2025, 15:15～16:45
Endothelial Damage Syndrome
- Chair
- Ho Joon Im
- （Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Korea）
- Takanori Teshima
- （Department of Hematology, Hokkaido University Faculty of Medicine, Japan）
Current perspectives of hepatic VOD/SOS after allogeneic hematopoietic cell transplantation; Korean real-world experience of defibrotide for severe hepatic VOD/SOS
- Presenters
- Jae-Ho Yoon
- （Catholic University of Korea Internal medicine VOD/SOS／International cooperative committee of KSBMT, Korea）
Transplant-Associated TMA: Current Clinical Experience and Emerging Insights
- Kyung-Nam Koh
- （Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Korea）
Advancing Early Diagnosis and Intervention in Sinusoidal Obstruction Syndrome/Veno-occlusive Disease
- Kimikazu Yakushijin
- （Department of Medical Oncology and Hematology, Kobe University Hospital, Japan）
Complement involvements and issues in TA-TMA after allogeneic hematopoietic cell transplantation
- Yusuke Okayama
- （Department of Hematology, Osaka Metropolitan University Graduate School of Medicine / Department of Hematology, Wakakusa-Daiichi Hospital, Japan）
